Effective Xiaflex administration for Peyronie disease involves back-to-back injections and achieving an erection with the first injection of each series. Optimizing dosage, dilution, and incorporating ...

According to iota Biosciences, the device is “designed to deliver electrical stimulation directly to the bladder wall, inducing contractions that facilitate bladder emptying in individuals impacted by ...

Active surveillance is effective for low-risk prostate cancer, with low metastasis and mortality rates over 10 years. The study underscores the need for improved risk stratification to minimize ...

“Particularly [in] bladder cancer, there's 2 new drugs on the market that are exceptionally expensive, but they do provide benefit to patients,” says Geoffrey N. Sklar, MD, FACS. In this interview, ...

Five-fraction SBRT showed noninferiority to conventional radiotherapy in localized prostate cancer, with 95.8% of patients free from failure at five years. SBRT offers a shorter treatment duration, ...

Neal Shore, MD, FACS, emphasizes the significance of the VISION and TheraP trials in supporting the FDA approval of Lutetium-177 for patients with mCRPC who have undergone androgen receptor inhibitor ...

Darolutamide's structure limits blood-brain barrier penetration, reducing central nervous system side effects and improving safety. It effectively delays metastasis and prolongs survival in ...

"This first paper was really to show that our research methodology was feasible and acceptable with pediatric urology patients and families. We've done that, and now we have a huge corpus of data that ...

Route of administration impacts patient compliance and convenience, influencing the choice of PD-1/PD-L1 agents. Duration of therapy affects patients' quality of life and is a key consideration in ...

Urologists need oncologists to provide systemic therapy insights and manage immune-related adverse events in combination therapy. Oncologists rely on urologists for expertise in local disease ...

The NRG-GU011 trial evaluates relugolix plus SBRT versus SBRT alone in men with PSA recurrence and PSMA-PET-detected metastases. The study addresses whether targeted radiation can delay hormone ...

Ga-PSMA and F-Fluciclovine PET/CT significantly increased radiotherapy target volumes post-prostatectomy, with F-Fluciclovine leading to more prostate bed boosts. F-Fluciclovine showed higher prostate ...